Search results
Results From The WOW.Com Content Network
Insys Therapeutics. Founded in 1990, Insys Therapeutics was an American specialty pharmaceutical company based in Chandler, Arizona. [ 1] Its main product was Subsys, a sublingual liquid form of the drug fentanyl. Fentanyl is an extremely fast-acting and powerful opioid used to relieve peaks of pain in cancer patients. [ 2][ 3]
Synergy Health plc (LSE: SYR) was a global company headquartered in the United Kingdom.The company provides specialist outsourced services to the healthcare and related markets around the world, including sterilization services for medical device and other manufacturers, decontamination of surgical instruments for hospitals and other medical practitioners together with related hygiene services.
A group of cancer victims asked a federal judge to block Johnson & Johnson's proposed bankruptcy settlement of tens of thousands of lawsuits alleging the company's baby powder and other talc ...
Title 11 of the United States Code. Harrington v. Purdue Pharma L.P., 603 U.S. ___ (2024), is a United States Supreme Court case regarding Chapter 11 of the Bankruptcy Code. [ 1] This case is about the settlement by Purdue Pharmaceutical for opioid victims who overdosed with the OxyContin drug produced by their company.
June 28, 2024 at 10:52 PM. By Brendan Pierson. (Reuters) - A federal judge on Friday rejected a bid by a group of cancer victims to block Johnson & Johnson from pursuing a proposed bankruptcy ...
For premium support please call: 800-290-4726 more ways to reach us
Biotech and pharmaceutical companies in the New York metropolitan area represent a significant and growing economic component of the New York metropolitan area, [1] [2] the most populous combined statistical area in the United States [3] and one of the most populous megacities in the world.
Synergy Pharmaceuticals Announces Plans to Initiate a Phase 2 Study of SP-333 for Opioid-Induced Constipation NEW YORK--(BUSINESS WIRE)-- Synergy Pharmaceuticals Inc. (NAS: SGYP) today announced ...